Literature DB >> 17973907

The expression of osteopontin is increased in vessels with blood-brain barrier impairment.

Y Iwanaga1, M Ueno, M Ueki, C-L Huang, S Tomita, Y Okamoto, T Ogawa, N Ueda, N Maekawa, H Sakamoto.   

Abstract

AIMS: We previously reported that the blood-brain barrier (BBB) function was deteriorated in vessels located along hippocampal fissures in stroke-prone spontaneously hypertensive rats (SHRSP). In this study, we examined changes of gene expression in the BBB-damaged vessels of SHRSP.
METHODS: Vascular samples were microdissected from the hippocampi of SHRSP and Wistar-Kyoto (WKY) as a control and the difference in gene expression between the BBB-damaged vessels in SHRSP and vessels without BBB damage in WKY was examined by a microarray. The differences in gene and protein expression between brain tissues in the two strains of rats were examined using real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), Western blotting and immunohistochemistry.
RESULTS: The microarray assay revealed that the ratio of osteopontin gene expression in the vascular tissue of the hippocampi of SHRSP to that of WKY was the highest among 8435 genes. Real-time RT-PCR analysis revealed that the gene expression of osteopontin was significantly increased in the hippocampal samples of SHRSP compared with that in the hippocampal samples of WKY rats or with that in the cortical samples of SHRSP. Immunohistochemical and Western blot analyses showed that the osteopontin protein expression was seen in perivascular ED1-positive macrophages/microglial cells located around hippocampal fissures and significantly increased in the hippocampi of SHRSP compared with that of WKY.
CONCLUSIONS: These findings indicate that the expression of osteopontin is increased in BBB-damaged vessels in hypertensive SHRSP compared with that in vessels without BBB impairment in WKY rats, suggesting a role for osteopontin in BBB function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973907     DOI: 10.1111/j.1365-2990.2007.00877.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  14 in total

1.  The expression of LDL receptor in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.

Authors:  Masaki Ueno; Bin Wu; Toshitaka Nakagawa; Yukiko Nagai; Masayuki Onodera; Cheng-Long Huang; Takashi Kusaka; Kenji Kanenishi; Haruhiko Sakamoto
Journal:  Histochem Cell Biol       Date:  2010-05-11       Impact factor: 4.304

2.  Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.

Authors:  Natalia Tiberti; Alexandre Hainard; Veerle Lejon; Xavier Robin; Dieudonné Mumba Ngoyi; Natacha Turck; Enock Matovu; John Enyaru; Joseph Mathu Ndung'u; Alexander Scherl; Loïc Dayon; Jean-Charles Sanchez
Journal:  Mol Cell Proteomics       Date:  2010-08-19       Impact factor: 5.911

3.  Acute intranasal osteopontin treatment in male rats following TBI increases the number of activated microglia but does not alter lesion characteristics.

Authors:  Amandine Jullienne; Mary Hamer; Elizabeth Haddad; Alexander Morita; Peter Gifford; Richard Hartman; William J Pearce; Jiping Tang; John H Zhang; Andre Obenaus
Journal:  J Neurosci Res       Date:  2019-03-20       Impact factor: 4.164

4.  Osteopontin predicts long-term functional outcome among ischemic stroke patients.

Authors:  M Mendioroz; I Fernández-Cadenas; A Rosell; P Delgado; S Domingues-Montanari; M Ribó; A Penalba; M Quintana; J Alvarez-Sabín; J Montaner
Journal:  J Neurol       Date:  2010-10-22       Impact factor: 4.849

5.  Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.

Authors:  Yi-Peng Han; Chen-Kai Ma; Shen-Qi Wang; Atsushi Enomoto; Yang Zhao; Masahide Takahashi; Jie Ma
Journal:  J Neurooncol       Date:  2014-05-31       Impact factor: 4.130

6.  Neuropsychiatric symptoms in patients with aortic aneurysms.

Authors:  Bernhard T Baune; Steven J Unwin; Frances Quirk; Jonathan Golledge
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

7.  Osteopontin expression during early cerebral ischemia-reperfusion in rats: enhanced expression in the right cortex is suppressed by acetaminophen.

Authors:  Sunanda S Baliga; Gary F Merrill; Mari L Shinohara; David T Denhardt
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

8.  Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.

Authors:  Qiu Yushi; Zhimin Li; Christina A Von Roemeling; Heike Doeppler; Laura A Marlow; Betty Y S Kim; Derek C Radisky; Peter Storz; John A Copland; Han W Tun
Journal:  Oncotarget       Date:  2016-05-31

Review 9.  Trauma-Induced Heterotopic Ossification Regulates the Blood-Nerve Barrier.

Authors:  Zbigniew Gugala; Elizabeth A Olmsted-Davis; Yuqing Xiong; Eleanor L Davis; Alan R Davis
Journal:  Front Neurol       Date:  2018-06-05       Impact factor: 4.003

10.  The Effect of Acute and Chronic Social Stress on the Hippocampal Transcriptome in Mice.

Authors:  Adrian M Stankiewicz; Joanna Goscik; Alicja Majewska; Artur H Swiergiel; Grzegorz R Juszczak
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.